Dr. Honggang Qian 钱红纲
Chief Physician
Soft Tissue and Retroperitoneal Tumor Center, Peking University Cancer Hospital, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive liver treatment, complex pancreatic surgery, retroperitoneal tumors, pancreatic neuroendocrine tumors, and molecular therapy for advanced cancer.
Dr. Qian is Deputy Director of the department and has practiced in this field since 1999. After earning a PhD in 2005, Dr. Qian studied in Austria for three months. In 2013, Dr. Qian completed advanced training at Mayo Clinic, focusing on laparoscopic pancreaticoduodenectomy combined with vascular resection and anastomosis. Dr. Qian leads multiple municipal and national research projects, participates in international studies, and has published over 10 articles.
Professional roles
- Secretary-General, Soft Tissue Tumor Branch, International Exchange and Promotion Association of Healthcare
- Vice Chair, Youth Committee, Liver Tumor Branch, International Exchange and Promotion Association of Healthcare
- Member, Multidisciplinary Clinical Research Collaboration Group, Pancreatic Cancer Professional Committee, China Anti-Cancer Association
- Young and Middle-aged Editorial Board Member, Chinese Journal of General Surgery
Name order: in Chinese the family name comes first (Qian Honggang). Papers usually list the name as Honggang Qian or Qian H.
Selected publications
25 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Cell Mol Med, 2026 (senior author): SFRP2 Potentiates Metastasis of Colon Cancer by Enhancing Snai1 Protein Stability via USP11. PubMed 42725854
- Mol Med Rep, 2024 (first author): [Corrigendum] Long non‑coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR‑522. PubMed 38426568
- Mol Med Rep, 2022 (first author): Long non‑coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR‑522. PubMed 35014686
- Chin Med J (Engl), 2014 (first author): A scoring system for prediction of early recurrence after liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. PubMed 25533817
- Zhonghua Wei Chang Wai Ke Za Zhi, 2012 (senior author): [Management of liver metastases of gastrointestinal stromal tumor]. PubMed 22454162
- World J Gastroenterol, 2005 (first author): Preliminary study on proteomics of gastric carcinoma and its clinical significance. PubMed 16419150
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion